JPRN-UMIN000027756已完成2 期
Single-arm phase II study of induction Gemcitabine+nab-paclitaxel followed by gemcitabine and concurrent radiotherapy for locally advanced pancreatic cancer - Induction Gem/NabPTX followed by G-CRT for LAPC, sPII
Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute0 个研究点目标入组 40 人开始时间: 2017年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe comorbidities (such as heart failure, renal failure, hepatic failure, paresis of intestine, illeus, poorly controlled diabetes(HbA1c>=10%) and poorly controlled hypertension) 2) History of unstable angina pectoris or myocardial infarction within 6 months before registration. 3) Synchronous or metachronous (within 5 years) malignancies except for early cancer. 4) Infectious disease requiring systemic treatment. 5) Female during pregnancy, within 28 days of postparturition, or during lactation and male expecting partner's pregnancy. 6) Severe psychological disorder. 7) Receiving continuous systemic corticosteroid or immunosuppressant treatment. 8) Unavailability of both allergy to bothe of iodine and gadolinium
研究者
相似试验
进行中（未招募）
1 期
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors - N/AEUCTR2005-005219-36-GBEli Lilly and Company Limited70
进行中（未招募）
不适用
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS TumorsEUCTR2005-005219-36-DEEli Lilly and Company Limited70
进行中（未招募）
不适用
Phase 2 single-arm studies of Gemcitabine in combination with Oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-004-GEMOXEUCTR2006-001065-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI156
已完成
2 期
Phase II single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumorssolid tumors in children10027655NL-OMON29764Institue Goustave Roussy16
进行中（未招募）
1 期
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors. - ITCC-004-GEMOXRefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-GBniversity Hospitals of Leicester NHS Trust, Research and Development Directorate156